What's Wrong With UnitedHealth Stock?

Core Viewpoint - UnitedHealth Group's stock has significantly declined, losing nearly half of its value over the past year, raising concerns about its future performance and investment viability [1][2]. Financial Performance - In its latest quarterly results, UnitedHealth reported adjusted earnings per share of $2.11, slightly exceeding analyst expectations of $2.10, but its revenue of $113.2 billion fell short of the anticipated $113.82 billion [3]. - For the current year, UnitedHealth forecasts revenue of approximately $439 billion, indicating a year-over-year decline of 2% [5]. Market Conditions - The Trump administration's proposal to keep Medicare Advantage rates flat at a 0.09% increase for 2027 contrasts sharply with analysts' expectations of at least a 4% increase, which poses a significant challenge for UnitedHealth and other health insurance companies [4]. - Rising healthcare costs and increased utilization rates are contributing to the company's struggles, making it difficult to achieve revenue growth in the near term [7]. Investor Sentiment - The stock has seen a drastic decline, with a 13% drop in early 2026 following a 35% decrease in 2025, leading to a lack of optimism for a quick recovery [1][8]. - The current market capitalization stands at $259 billion, with a dividend yield of 3.06%, but the outlook remains bleak for short-term recovery [6][7].